Center for Neurointestinal Health, Gastroenterology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Eating Disorders Clinical and Research Program, Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, USA.
Int J Eat Disord. 2021 Jun;54(6):952-958. doi: 10.1002/eat.23414. Epub 2020 Nov 26.
Little research exists on Rome IV disorders of gut-brain interaction (DGBI; formerly called functional gastrointestinal disorders) in outpatients with eating disorders (EDs). These data are particularly lacking for avoidant/restrictive food intake disorder (ARFID), which shares core features with DGBI. We aimed to identify the frequency and nature of DGBI symptoms among outpatients with EDs.
Consecutively referred pediatric and adult patients diagnosed with an ED (n = 168, 71% female, ages 8-76 years) in our tertiary care ED program between March 2017 and July 2019 completed a modified Rome IV Questionnaire for DGBI and psychopathology measure battery.
The majority (n = 122, 72%) of participants reported at least one bothersome gastrointestinal symptom. Sixty-six (39%) met criteria for a DBGI, most frequently functional dyspepsia-post-prandial distress syndrome subtype (31%). DGBI were surprisingly less frequent among patients with ARFID (30%) versus EDs that are associated with shape or weight concerns (45%; X [1] = 3.61, p = .058, Cramer's V = .147). Among those with ARFID, DGBI presence was associated with the fear of aversive consequences prototype and multiple comorbid prototype presence.
We demonstrated notable overlap between DGBI and EDs, particularly post-prandial distress symptoms. Further research is needed to examine if gastrointestinal symptoms predict or are a result of greater ED pathology, including ARFID prototypes.
在患有饮食障碍(ED)的门诊患者中,关于肠-脑相互作用障碍(DGBI;以前称为功能性胃肠道疾病)的研究很少。对于与 DGBI 具有核心特征的回避/限制型食物摄入障碍(ARFID)来说,这些数据尤其缺乏。我们旨在确定 ED 门诊患者中 DGBI 症状的频率和性质。
在 2017 年 3 月至 2019 年 7 月期间,我们的三级护理 ED 项目连续收治了被诊断为 ED 的儿科和成年患者(n=168,71%为女性,年龄 8-76 岁),他们完成了罗马 IV 修订版 DGBI 问卷和精神病理学测量工具包。
大多数患者(n=122,72%)报告至少有一个烦人的胃肠道症状。66 例(39%)符合 DGBI 标准,最常见的是餐后不适综合征功能性消化不良亚型(31%)。令人惊讶的是,在 ARFID 患者(30%)中 DGBI 较不常见,而与体型或体重相关的 ED (45%;X [1] = 3.61,p =.058,Cramer's V =.147)。在 ARFID 患者中,DGBI 的存在与对厌恶后果原型和多种共病原型的存在相关。
我们证明了 DGBI 与 ED 之间存在显著重叠,尤其是餐后不适症状。需要进一步研究以检查胃肠道症状是否预测或导致更大的 ED 病理,包括 ARFID 原型。